Literature DB >> 9542697

Changing patterns of psychotropic medications prescribed by child psychiatrists in the 1990s.

D J Safer1.   

Abstract

The active (1994) and closed (1988 to 1992) outpatient records of youths seen in four separate community mental health centers (CMHC) in Baltimore County, Maryland were reviewed in mid-1994 to document recent changes in the medication-prescribing practices of local child psychiatrists. Inpatient summaries of previously hospitalized CMHC youths were also reviewed to supplement the outpatient medication assessment with hospital data. This regional survey of medication treatments in child psychiatry revealed that, during the half decade before 1994, there was an increase in overall psychotropic medication treatment, multiple concurrent medication treatments (polypharmacy), and antidepressant treatment with serotonin reuptake inhibitors (SRIs). Inpatient youths were consistently prescribed more psychotropic medications and diagnosed more frequently with major depressive disorder than outpatients. Medications typically used to first treat mood disorders became the predominant medication prescribed for both outpatients and inpatients by child psychiatrists in 1994, leading to a proportional decline in prescribed stimulant treatment. The shift from tricyclic antidepressants to SRI antidepressants in the 1990s by child psychiatrists matches the same recent practice shift by adult psychiatrists. Likewise, the increased prescription of drugs to treat mood disorders and the increased rate of polypharmacy notable of late among child psychiatrists now also mirrors adult psychiatry practice. Wide geographic variations in neuroleptic and antidepressant medication patterns were noted, even among facilities in the same metropolitan region. After psychiatric hospitalization, most youths who continued treatment at a CMHC outpatient clinic discontinued their inpatient medications within 3 months; the sole exception were children who had been placed on psychostimulants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9542697     DOI: 10.1089/cap.1997.7.267

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  9 in total

Review 1.  Therapeutics of aggression in children.

Authors:  D S Pine; E Cohen
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Pediatric psychotropic polypharmacy.

Authors:  Mark R Zonfrillo; Joseph V Penn; Henrietta L Leonard
Journal:  Psychiatry (Edgmont)       Date:  2005-08

3.  Effects of psychotherapy for depression in children and adolescents: a meta-analysis.

Authors:  John R Weisz; Carolyn A McCarty; Sylvia M Valeri
Journal:  Psychol Bull       Date:  2006-01       Impact factor: 17.737

4.  Pharmacotherapy and postdischarge outcomes of child inpatients admitted for aggressive behavior.

Authors:  Joseph C Blader
Journal:  J Clin Psychopharmacol       Date:  2006-08       Impact factor: 3.153

5.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

6.  Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial.

Authors:  Rozita Davari-Ashtiani; Mahin Eslami Shahrbabaki; Katayoon Razjouyan; Homayoun Amini; Homa Mazhabdar
Journal:  Child Psychiatry Hum Dev       Date:  2010-12

7.  Adjunctive divalproex versus placebo for children with ADHD and aggression refractory to stimulant monotherapy.

Authors:  Joseph C Blader; Nina R Schooler; Peter S Jensen; Steven R Pliszka; Vivian Kafantaris
Journal:  Am J Psychiatry       Date:  2009-11-02       Impact factor: 18.112

8.  Parental attitudes toward the prescription of psychotropic medications for their children.

Authors:  Fatima A Al-Haidar
Journal:  J Family Community Med       Date:  2008-01

9.  Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014.

Authors:  Sandra Lopez-Leon; Manuel I Lopez-Gomez; Barbara Warner; Leon Ruiter-Lopez
Journal:  Daru       Date:  2018-06-27       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.